Bcg in Tumor Immunotherapy (Q39775805)

14 September 2017

1 reference

title

BCG in tumor immunotherapy (English)

1 reference

14 September 2017

Bcg in Tumor Immunotherapy (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

1 reference

1 reference

R. W. Baldwin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360797

7 April 2023

M. V. Pimm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360797

7 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=360797

7 April 2023

publication date

1 January 1978

1 reference

Advances in Cancer Research

14 September 2017

published in

1 reference

14 September 2017

volume

28

1 reference

14 September 2017

page(s)

91-147

1 reference

Endotoxin and double stranded RNA render macrophages cytotoxic

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumour-specific immunity against spontneous rat tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Neoantigens on spontaneous and carcinogen-induced rat tumors defined by in vitro lymphocytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BGG immunotherapy of local subcutaneous growths and post-surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BCG Immunotherapy of a Rat Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

B.C.G. suppression of pulmonary metastases from primary rat hepatomata

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunogenicity of rat hepatoma membrane fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Influence of orally administered B.C.G. on growth of transplanted rat tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Bacillus Calmette-Guérin contact immunotherapy of local and metastatic deposits of rat tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6′-dimycolate)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunotherapy of Cancer With Nonliving Mycobacteria and Cord Factor (Trehalose-6,6′-dimycolate) in Aqueous Medium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Suppression of Urethan-Induced Lung Adenomas in Mice Treated with Trehalose-6,6-Dimycolate (Cord Factor) and Living Bacillus Calmette Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Isolation and characterization of tumour-specific antigen from the serum of rats bearing transplanted aminoazo dye-induced hepatomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Lymphatic metastasis and its inhibition: an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Therapeutic effect of intratumoral injection of BCG and other substances in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumor Regression Mediated by Mycobacterium bovis (Strain BCG). Effects of Isonicotinic Acid Hydrazide, Cortisone Acetate, and Antithymocyte Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Cancer, Differentiation and Embryonic Antigens: Some Central Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Antibodies and antigen expression in human melanoma detected by the immune adherence test

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Delayed hypersensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Induction of tumor resistance with BCGa-associated tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Macrophage content of tumours in relation to metastatic spread and host immune reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

The Current Status of BCG Immunization Against Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumour-associated transplantation antigen in sera of rats with large RSV-induced sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Influence of cell-free tumour-associated antigen preparations on the development of immunity to chemically induced rat tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Macrophages in syngeneic animal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Cell-mediated immunity to human tumors. Abrogation by serum factors and nonspecific effects of oral BCG therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Studies on tubercle bacillus-histiocyte relationship. V. Passive transfer of cellular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: Lack of tumour specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Trehalose covalently conjugated to bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumor resistance in rats immunized to fetal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Brief Communication: Immunotherapy of Cancer: Tumor Suppression and Regression by Cell Walls of Mycobacterium phlei Attached to Oil Droplets2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Active immunotherapy with B.C.G. for recurrent malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Evaluation of BCG Administered by Scarification for Immunotherapy of Metastatic Hepatocarcinoma in the Guinea Pig2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Antibodies against BCG antigen 60 in mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunopotentiation with BCG: dimensions of a specific antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunotherapy of leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BCG as Adjuvant Immunotherapy for Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Discrimination Between Neoplastic and Non-Neoplastic Cells In Vitro by Activated Macrophages12

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

New method of immunotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Methanol extraction residue of BCG in the treatment of transplanted rat tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Granulomatous hepatitis: a complication of B.C.G. immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Genetic variation ofin vitro cytolytic activity andin vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Coupling PPD to tumour cells enhances their antigenicity in BCG-primed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Cord factor and related trehalose esters

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immune response to Mycobacterium tuberculosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Extraction of Tumor-Specific Antigen From Cells and Plasma Membranes of Line-10 Hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

ALLERGIC IRRITABILITY : THE FORMATION OF ANTI-SHEEP HEMOLYTIC AMBOCEPTOR IN THE NORMAL AND TUBERCULOUS GUINEA PIG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Controlled trial of active immunotherapy in management of stage IIB malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunopotentiation With BeG. I. Immune Response to Different Strains and Preparations2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Regional immunotherapy of lung cancer with intrapleural B.C.G

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Intrapleural B.C.G. immunostimulation in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Clinical and Histologic Correlation of Melanoma Regression After Intralesional BCG Therapy: A Case Report2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Intralesional BCG in the treatment of metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Active immunotherapy for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Enhanced tumor growth in animals pretreated with complete Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

The biologic activity of MER-BCG in experimental systems and preliminary clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Combination ofC. parvum and specific immunization against artificial pulmonary metastases in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunopotentiation with BCG. II. Modulation of the Response to Sheep Red Blood Cells2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Shared antigens between Mycobacterium bovis (BCG) and other bacterial species

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Stimulation of Lymphoid Cells by Components of BCG2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Activation of lymphoid cells by BCG in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Intra-tumour host cells of transplanted rat neoplasms of different immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guérin (BCG)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumour inhibition mediated by BCG in immunosuppressed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Effect of intravenous B.C.G. in guineapigs and pertinence to cancer immunotherapy in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Specific tubercle antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Decreased phagocytosis by peritoneal macrophages from BCG-treated mice: induction of the phagocytic defect in normal macrophages with BCG in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Alterations of macrophage functions by mediators from lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunological monitoring and immunotherapy in carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Direct Comparison of Three Isotopic Release Microtoxicity Assays as Measures of Cell-Mediated Immunity to Gross Virus-Induced Lymphomas in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigenicity of the Tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Modulation of the immune response of guinea pigs by repeated BCG scarification

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Letter: Intrapleural B.C.G. treatment of experimental lung tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BCG immunotherapy of rat tumours in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Bcg therapy of pleural and peritoneal growth of transplanted rat tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Influence of whole body irradiation on bcg contact suppression of a rat sarcoma and tumour-specific immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

C. parvum suppression of rat tumours in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

BCG treatment of malignant pleural effusions in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

A 5-year controlled study of B.C.G. and radiotherapy inoperable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Effector cells for antibody-dependent cell mediated cytotoxicity. I. Increased cytotoxicity after priming with BCG-SS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumor progression and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunogenic properties of rat hepatoma subcellular fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Antitumor immunity, V.BCG-induced growth inhibition of murine tumors. Effect of hydrocortisone, antiserum against theta antigen, and gamma-irradiated BCG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Inhibition of pulmonary tumour development in rats sensitised to rat embryonic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumor regression caused by endotoxins and mycobacterial fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Active tumor immunotherapy with BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of moloney sarcoma regression or progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Intra-lesional injection of immunostimulants in bilateral rat tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Neuraminidase and tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Natural Occurrence of Lymphocytes Showing Cytotoxic Activity to BALB/c Radiation-Induced Leukemia RL ♂ 1 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Eradication of Microscopic Lymph Node Metastases After Injection of Living BeG Adiacent to the Primary Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Hazards and Complications of BCG Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Complications of BCG immunotherapy in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

An antigenic analysis of the mycobacteria, Mycobacterium fortuitum, Myco. kansasii, Myco. phlei, Myco. smegmatis and Myco. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Soluble tumour-specific antigen and its relationship to tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Antibodies and Soluble Tumour-specific Antigens in Blood and Lymph of Rats with Chemically Induced Sarcomata

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Macrophages in solid tumors. I. Immunologically specific effector cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

The adjuvant effect of microbial products on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Introduction of "natural" killer' cells by BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960647-8

7 January 2021

Annales d'immunologie

3

128c

653

Audibert

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

Induction of Tumor-Immune Responses and Their Interaction with the Developing Tumor

7 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

33

34

1627

Bogden

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

58

36

1731

Dubois

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

71

36

4459

Fidler

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

73

1

31

Florentin

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

79

1

41

Geffard

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

84

38

69

Greager

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

89

1

99

Gutterman

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

Cancer Treatment Reports

90

60

177

Gutterman

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

93

1

17

Halle-Pannenko

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

128

1

55

Jurczyk-Procyk

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

135

1

227

Leclere

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

168

36

1680

Minden

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

178

1

93

Morton

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

188

21

1281

Old

1961

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

218

37

3385

Rao

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

223

37

2860

Reisfeld

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

225

author name string

Roscoe

publication date

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

231

1

69

Schwarzenberg

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

Virulence of Six Strains of Mycobacterium bovis (BCG) in Mice

7 April 2023

236

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

244

34

3262

Sparks

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

250

26

1591

Stjernswärd

1966

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

258

1

25

Turcotte

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

259

31

1655

Vaage

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

260

32

193

Vaage

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

261

33

493

Vaage

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

262

34

2979

Vaage

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues

7 April 2023

281

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

284

2

201

Yarkoni

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60647-8

7 April 2023

Identifiers

0 references

1 reference